[1] CHAROENKWAN P, ANUWONGCHAROEN N, NANTASENAMAT C, et al. In silico approaches for the prediction and analysis of antiviral peptides: a review[J].Curr Pharm Des, 2020, 27(18): 2180
[2] KAPLAN Z, OZGU-ERDINC AS. Prediction of preterm birth: maternal characteristics, ultrasound markers, and biomarkers: an updated overview[J].J Pregnancy, 2018, 2018(3):1
[3] 张莉, 杨书才, 唐景云, 等. 1型糖尿病患者血浆外泌体蛋白质组学分析[J].国际检验医学杂志, 2020, 41(5): 588
ZHANG L, YANG SC, TANG JY, et al. Proteomics analysis of plasma exocrine in type 1 diabetes mellitus[J].Int J Lab Med, 2020, 41(5): 588
[4] 刘鹤鸣, 刘海艳, 马晓峰, 等.蛋白质组学在骨科的应用现状[J].中国矫形外科杂志, 2020, 28(5): 435
LIU HM, LIU HY, MA XF, et al. Current application of proteomics in orthopedic field[J].Orthop J Chin, 2020, 28 (5): 435
[5] 杨佳, 李霞, 王家林. 蛋白质组学在食管癌诊断应用进展[J].中华肿瘤防治杂志, 2020, 27(2): 160
YANG J, LI X, WANG JL. Application progress of proteomics in diagnosis of esophageal cancer[J].Chin J Cancer Prev Treat, 2020, 27(2): 160
[6] 陈芊凝. 蛋白组学研究方法概述[J].价值工程, 2020, 39(3): 243
CHEN QN. Overview of proteomics research methods[J].Val Eng, 2020, 39(3): 243
[7] 张墨, 陈骊珠, 杨泽宇, 等. 基于iTRAQ蛋白质组学技术对前列腺癌血清标志物的筛查[J].现代肿瘤医学, 2018(1): 18
ZHANG M, CHEN LZ, YANG ZY, et al. Screening of serum markers of prostate cancer based on iTRAQ proteomics[J].Mod Oncol, 2018,(1): 18
[8] SUN DY, FU JT, LI GQ, et al. iTRAQ-and LC-MS/MS-based quantitative proteomics reveals Pqlc2 as a potential regulator of hepatic glucose metabolism and insulin signalling pathway during fasting[J].Clin Exp Pharmacol Physiol, 2020, 48(2): 238
[9] 王素兰, 高华萍, 张菁, 等. 基于稳定同位素标记和平行反应监测的蛋白质组学定量技术用于肝癌生物标志物的筛选和验证[J].色谱, 2017, 35(9): 934
WANG SL, GAO HP, ZHANG J, et al. Screening and validation of biomarkers for liver cancer based on stable isotope labeling and parallel reaction monitoring[J].Chromatography, 2017, 35(9): 934
[10] 尚京川, 易发平, 吴民军, 等. 蛋白质组学技术筛选肝癌血浆/血清中的差异蛋白质[J].重庆医科大学学报, 2010, 35(8): 1212
SHANG JC, YI FP, WU MJ, et al. Screening of differentially expressed proteins in plasma and serum of hepatocellular carcinoma by proteomics[J].J Chongqing Med Univ, 2010, 35(8): 1212
[11] SLANY A, HAUDEK-PRINZ V, ZWICKL H, et al. Myofibroblasts areimportant contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling[J].Electropho, 2013, 34(24): 3315
[12] AWAN FM, NAZ A, OBAID A, et al. Identification of circulating biomarker candidates for hepatocellular carcinoma (HCC):anintegrated prioritization approach[J].PLoS One, 2015, 10(9): e0138913
[13] 谢玲林. 肝细胞癌转移相关蛋白的iTRAQ定量蛋白质组学研究[J].基因组学与应用生物学, 2017, 36(9): 3552
XIE LL. iTRAQ quantitative proteomic study on metastasis related proteins of hepatocellular carcinoma[J].Genomics Appl Biol, 2017, 36(9): 3552
[14] 王运九. 蛋白核心岩藻糖基化在原发性肝癌中的临床意义及应用研究[D].上海: 第二军医大学, 2017
WANG YJ. Clinical Significance and Application of Protein Core Fucosylation in Primary Liver Cancer[D].Shanghai: Second Military Medical University, 2017
[15] 王江红, 李启英, 石洋, 等. 人原发性肝癌相关抗原的蛋白质组学初步研究[J].第三军医大学学报, 2017, 39(1): 72
WANG JH, LI QY, SHI Y, et al. Preliminary proteomic study on human hepatocellular carcinoma associated antigen[J].J Third Military Med Univ, 2017, 39(1): 72
[16] 刘博, 黄志强, 周宁新, 等. 肝癌细胞系SMMC7721蛋白质组学初步分析[J].中华实验外科杂志, 2004(12): 32
LIU B, HUANG ZQ, ZHOU NX, et al. Proteomic analysis of hepatoma cell line SMMC7721[J].Chin J Exp Surg, 2004(12): 32
[17] 陈辉. 原发性肝细胞癌组织分泌蛋白质组的定量蛋白质组学研究[D].福州: 福建医科大学, 2017
CHEN H. Quantitative Proteomic Study of Secretory Proteome in Primary Hepatocellular Carcinoma[D].Fuzhou: Fujian Medical University, 2017
[18] YI X, LUK JM, LEE NP, et al. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence[J].Mol Cell Proteomics, 2008, 7(2): 315
[19] 耿鑫. 蛋白质组学在筛选肝癌早期诊断血清标志物中的应用研究[D].天津: 天津医科大学, 2007
GENG X. Application of Proteomics in Screening Serum Markers for Early Diagnosis of Liver Cancer[D].Tianjin: Tianjin Medical University, 2007
[20] 杨磊, 荣维淇, 肖汀, 等. 应用分泌/释放蛋白质组学鉴定HBV相关的肝细胞癌血浆标志物[J].中国科学: 生命科学, 2013, 43(8): 663
YANG L, RONG WQ, XIAO T, et al. Identification of plasma markers of HBV related hepatocellular carcinoma by secretory / release proteomics[J].Sci Sin Vit, 2013, 43(8): 663
[21] 李素贞, 徐锋, 徐平. 高转移肝癌细胞HCCLM6的酪氨酸磷酸化蛋白质组学研究[J].军事医学, 2019, 43(2): 106
LI SZ, XU F, XU P. Proteomics of tyrosine phosphorylation in highly metastatic hepatocellular carcinoma cell line HCCLM6[J].Military Med, 2019, 43(2): 106
[22] 齐英姿, 邓晨, 苏纳, 等. 肝癌细胞系Hep3B的泛素化蛋白质组学[J].生物工程学报, 2016, 32(10): 1443
QI YZ, DENG C, SU N, et al. Ubiquitination proteomics of hepatocellular carcinoma cell line Hep3B[J].J Bioeng, 2016, 32(10): 1443
[23] 张涛. 高、低转移潜能乳腺癌细胞的差异表达蛋白研究[D].重庆:重庆医科大学,2008
Zhang T. Differentially Expressed Proteins in Breast Cancer Cells with High and Low Metastatic Potential [D].Chongqing: Chongqing Medical University, 2008
[24] 饶希午. 基于蛋白质组学的消癌解毒方干预肝癌大鼠的作用机制研究[D].南京: 南京中医药大学, 2019
RAO XW. Study on the Mechanism of Xiaoai Jiedu Recipe on Liver Cancer Rats Based on Proteomics[D].Nanjing: Nanjing University of Traditional Chinese Medicine, 2019
[25] 叶丽虹, 秦宵然, 张晓东, 等. 原肌球蛋白、波形纤维蛋白和热休克蛋白70在肝癌转移亚细胞中表达上调[J].中国生物化学与分子生物学报, 2005(2): 243
YE LH, QIN XR, ZHANG XD, et al. Up regulation of expression of tropomyosin, vimentin and heat shock protein 70 in metastatic hepatocellular carcinoma[J].Chin J Biochem Mol Biol, 2005(2): 243
[26] 苏刚. 分泌蛋白及外泌体对肝癌细胞影响的蛋白质组学研究[D].兰州: 兰州大学, 2018
SU G. Proteomic Study on the Effects of Secretory Proteins and Exosomes on Hepatoma Cells[D].Lanzhou: Lanzhou University, 2018
[27] 孙颖. 肝癌细胞侵袭转移相关的蛋白质组和泛素化蛋白质组研究[D].福州: 福建农林大学, 2018
SUN Y. Proteome and Ubiquitination Proteome Related to Invasion and Metastasis of Hepatocellular Carcinoma[D].Fuzhou: Fujian agriculture and Forestry University, 2018
[28] 傅斌生,刘炜,张剑文,等.肝癌转移相关分子的血清蛋白质组学分析[J].南方医科大学学报,2009,29(9):1775
FU BS, LIU W, ZHANG JW, et al. Serum proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma[J].J South Med Univ, 2009, 29(9):1775
[29] ALEXANDER KL, NEARING M, CHAKRABORTY A, et al. Sa1210 ST6Gal-I is upregulated in barrett's esophagus stem cells and dysplasia[J].Gastroenterology, 2020, 158(6):S313
[30] 刘盛东.肝细胞癌肝内血管侵犯相关分子标记的血清蛋白质组学研究[D].上海:复旦大学, 2010
LIU SD. The Serum Proteomics Study on Molecular Markers Relatedto Vascular Invasion of Hepatocellular Carcinoma[D].Shanghai: Fudan University, 2010
[31] JUN M, JENNY W, LALEH SG, et al. Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data[J].Genomics, 2020, 112(1):647
[32] GOU L,WANG W,TONG A, et al. Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma[J].J Mol Med, 2011, 89(8): 817
[33] 高艳艳. 基于SWATH-MS技术的肝癌定量蛋白质组学和激酶组学研究[D].北京: 中国人民解放军军事医学科学院, 2017
GAO YY. Quantitative Proteomics and Kinase Analysis of Liver Cancer Based on SWATH-MS Technology[D].Beijing: Chinese Academy of Military Medical Sciences, 2017
[34] 王艳茹. 血清标记物M/Z 6455.5Da蛋白质多肽抗肝癌作用及其机制研究[D].郑州: 郑州大学, 2016
WANG YR. Anti Hepatoma Effect and Mechanism of Serum Marker M/Z 6455.5DA Protein Peptide[D].Zhengzhou: Zhengzhou University, 2016
[35] 侯国军. 多组学整合在肝癌恶性进展研究中的应用与相关分子机制探讨[D].上海: 第二军医大学, 2017
HOU GJ. Application of Multi Omics Integration in the Study of Malignant Progression of Liver Cancer and Discussion of Related Molecular Mechanisms[D].Shanghai: Second Military Medical University, 2017
